BioPharma Credit PLC - End Period Cash Flow
BioPharma Credit PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "End-Period-Cash-Flow" stands at 0.0099 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2025.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.1469 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.1469 Billion United States Dollars.
The 3 year change is -0.1617 Billion United States Dollars.
The 5 year change is -0.23 Billion United States Dollars.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2020, to it's latest available value, on 06/30/2025, is +0.0976 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2019, to it's latest available value, on 06/30/2025, is -1.21 Billion.
End Period Cash Flow for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Berkshire Hathaway Inc - End Period Cash Flow | 1,088,030,244,864.00 |
 | Blackstone Group Inc - End Period Cash Flow | 186,696,990,720.00 |
 | BlackRock Inc - End Period Cash Flow | 166,346,604,544.00 |
 | KKR & Co LP - End Period Cash Flow | 119,832,821,760.00 |
 | Mitsubishi Corp. - End Period Cash Flow | 89,722,540,958.42 |